The number of Anesthesia and Respiratory pipeline products in 2020 saw a 327% rise globally when compared to Anesthesia and Respiratory Pipeline Products in 2019, according to GlobalData’s Pipeline Products database. This compares to an 34% rise for all pipeline medical devices in 2020 compared to 2019.
The global Anesthesia and Respiratory Devices market was worth $20.67bn in 2019 and is expected to reach $18.33bn by 2025, according to GlobalData’s analysis.
Anesthesia and Respiratory Devices Pipeline Products by categories: Respiratory Devices has the most devices
Looking at the device categories of Pipeline Products , Respiratory Devices accounted for the largest proportion (82.57%) in 2020, followed by Airway Management (8.26%) and Diagnostic and Measurement Devices (4.59%).
Of the global medical devices market value, the Anesthesia and Respiratory Devices market held a 4% share worth $20bn in 2020 and is expected to reach $18.33bn by 2025.
Anesthesia and Respiratory Devices development activity: Advanced stage of development leads
Devices at an advanced stage of development (in clinical trials, in the approval process, already approved in Europe or the rest of the world) accounted for 39.27% of medical devices in 2020, compared with 41.18% in 2019. The number of devices at the In Approval stage inclined by 433% in 2020, when compared with 2019.
The In Approval stage is considered to be the period where the manufacturer is waiting for final approval from regulators, following completion of the required development steps.
A decrease in products awaiting approval would indicate less new products entering the market in the coming months, while an increase indicates more devices entering the market, posing a market share threat to existing marketed devices.
North America tops pipeline Anesthesia and Respiratory Devices products activity
Comparing the number of pipeline Anesthesia and Respiratory Devices products activity in different regions of the globe, North America held the top position (52%) during 2020, followed by Asia-Pacific (24%), and Europe (16%).
On a country level, the US had the most pipeline Anesthesia and Respiratory Devices during the year, representing the largest share (53%) of Anesthesia and Respiratory Pipeline Products . In second place was India (22%), followed by Israel (3%).
New pipeline Anesthesia and Respiratory medical devices: Expected to be approved by 2025
According to GlobalData, approximately 18% of pipeline Anesthesia and Respiratory Devices in 2020 were expected to receive regulatory approval by the end of 2025. The leading categories for devices expected to receive regulatory approval by the end of 2025 was Ventilators, at 2% of devices. Differences in regulatory approval timelines reflect the stage of development for a device, the device complexity or risk categorization (or device class) or if there are changes in regulatory oversight.
Lundquist tops Anesthesia and Respiratory Devices development in 2020
According to GlobalData, top ten medical device companies accounted for 12.39% of pipeline Anesthesia and Respiratory Devices activity during 2020. The leading company for developing Anesthesia and Respiratory Devices was Lundquist with 2.29%, followed by University of Nebraska at 1.38%.
Companies launching new medical devices are more likely to disrupt existing market share or are better able to defend existing share.
Company-developed Pipeline Products lead Anesthesia and Respiratory Devices in development
Looking at the share of activity in terms of Anesthesia and Respiratory Pipeline Products developers, company-developed Pipeline Products accounted for a 58% share of the Anesthesia and Respiratory medical devices market, while institute-developed Pipeline Products held the remaining share.
The medical devices pipeline data used in this article were extracted from Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database covers all medical devices which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. Pipeline Products are covered from various authenticated sources like company websites, SEC filings, conference presentations, analyst presentations, news releases, grants etc. The information is collected by following systematic research techniques and proprietary methodology.